Hernandez R J, Sullivan D B, Chenevert T L, Keim D R
Department of Radiology, University of Michigan Hospitals, Ann Arbor 48109.
AJR Am J Roentgenol. 1993 Aug;161(2):359-66. doi: 10.2214/ajr.161.2.8333378.
The purpose of this study was to describe the musculoskeletal MR findings in childhood dermatomyositis and to correlate MR findings with indicators of disease activity such as muscle strength and serum levels of muscle enzymes.
This prospective study included 24 children: 19 children with dermatomyositis and five control subjects. The diagnosis of dermatomyositis was established by clinical findings and serum levels of muscle enzymes in all patients, electromyography in six patients, and biopsy in four patients. At the time of the initial MR evaluation, patients were classified on the basis of clinical findings as having active (n = 15) or inactive (n = 4) disease. A total of 44 MR evaluations of patients with dermatomyositis were included in the study: 19 initial MR examinations and 12 examinations repeated after 4-6 months of therapy in patients with active disease. An additional 13 examinations were performed on five patients. Conventional T1-weighted (SE 600/20) and T2-weighted (SE 2500/80) spin-echo and fat-suppressed MR images were obtained. The T2-weighted images (TE = 80) were used for comparison. In addition to the visual assessment, ratios between the signal intensity of muscles (gluteus, adductors, quadriceps, and hamstrings) and the signal intensity of subcutaneous fat in the same tomographic section were calculated.
All patients with clinically active disease (n = 15) had abnormal findings on MR studies, whereas those with inactive disease (n = 4) had normal MR findings. Signal-intensity ratios of patients with active disease were greater than those in control subjects, whereas the ratios in patients with inactive disease were not different from those in control subjects. After 4-6 months of therapy, the average signal-intensity ratios of treated patients with repeated MR evaluations (n = 12) differed from ratios obtained before therapy in the same patients, but were not different from the ratios in control subjects. Other MR findings observed were perimuscular edema, enhancement of the chemical-shift artifact, and inflammatory changes of subcutaneous fat. Fat-suppressed imaging enhanced visualization of abnormalities. Markedly abnormal signal intensities of muscle were associated with marked elevations of serum levels of muscle enzymes; however, abnormal MR findings were visualized with normal serum levels of muscle enzymes.
Findings of active childhood dermatomyositis on T2-weighted MR images include increased signal intensity in affected muscle, perimuscular edema, enhanced chemical-shift artifact, and increased signal intensity in subcutaneous fat. After therapy, signal intensity of muscle returns to normal. These MR findings are enhanced on fat-suppressed images.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究旨在描述儿童皮肌炎的肌肉骨骼磁共振成像(MR)表现,并将MR表现与疾病活动指标(如肌力和肌肉酶血清水平)相关联。
这项前瞻性研究纳入了24名儿童,其中19名皮肌炎患儿和5名对照受试者。所有患者均根据临床表现和肌肉酶血清水平确诊皮肌炎,6例患者进行了肌电图检查,4例患者进行了活检。在首次MR评估时,根据临床表现将患者分为疾病活动组(n = 15)和非活动组(n = 4)。本研究共纳入了44次对皮肌炎患者的MR评估:19次初始MR检查,以及对15例活动期疾病患者在治疗4 - 6个月后重复进行的12次检查。另外对5例患者进行了13次检查。获得了常规的T1加权(SE 600/20)、T2加权(SE 2500/80)自旋回波和脂肪抑制MR图像。使用T2加权图像(TE = 80)进行比较。除了视觉评估外,还计算了肌肉(臀肌、内收肌、股四头肌和腘绳肌)信号强度与同一断层图像中皮下脂肪信号强度的比值。
所有临床活动期疾病患者(n = 15)的MR检查均有异常表现,而非活动期疾病患者(n = 4)的MR表现正常。活动期疾病患者的信号强度比值高于对照受试者,而非活动期疾病患者的比值与对照受试者无差异。治疗4 - 6个月后,接受重复MR评估的治疗患者(n = 12)的平均信号强度比值与治疗前同一患者的比值不同,但与对照受试者的比值无差异。观察到的其他MR表现包括肌周水肿、化学位移伪影增强和皮下脂肪的炎症改变。脂肪抑制成像增强了异常的可视化。肌肉明显异常的信号强度与肌肉酶血清水平的显著升高相关;然而,在肌肉酶血清水平正常时也可观察到异常的MR表现。
儿童活动期皮肌炎在T2加权MR图像上的表现包括受累肌肉信号强度增加、肌周水肿、化学位移伪影增强和皮下脂肪信号强度增加。治疗后,肌肉信号强度恢复正常。这些MR表现在脂肪抑制图像上更为明显。(摘要截断于400字)